During the past decade, University of Washington AIDS CRS conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Washington AIDS CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 81 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "AIDS Clinical Trials Group" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Merck Sharp & Dohme LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Washington AIDS CRS" #1 collaborator was "Glaxo Wellcome" with 8 trials as a collaborator, "AIDS Clinical Trials Group" with 7 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "University of Washington AIDS CRS" are "HIV Infections" (80 trials), "Pneumonia, Pneumocystis Carinii" (5 trials), "HIV Infection" (3 trials), "Hepatitis B" (3 trials) and "Mycobacterium Avium-intracellulare Infection" (3 trials). Many other conditions were trialed in "University of Washington AIDS CRS" in a lesser frequency.

Most popular intervention types in "University of Washington AIDS CRS" are "Drug" (75 trials), "Biological" (14 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (20 trials), "Didanosine" (11 trials), "Stavudine" (10 trials), "Lamivudine" (9 trials) and "Placebo" (9 trials). Other intervention names were less common.

The vast majority of trials in "University of Washington AIDS CRS" are 83 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Washington AIDS CRS". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in University of Washington AIDS CRS, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Washington AIDS CRS, 16 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".